These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38512801)

  • 1. Thermoneutral temperature exposure enhances slow-wave sleep with a correlated improvement in amyloid pathology in a triple-transgenic mouse model of Alzheimer's disease.
    Wang J; Huffman D; Ajwad A; McLouth CJ; Bachstetter A; Kohler K; Murphy MP; O'Hara BF; Duncan MJ; Sunderam S
    Sleep; 2024 Jun; 47(6):. PubMed ID: 38512801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats.
    Hector A; Provost C; Delignat-Lavaud B; Bouamira K; Menaouar CA; Mongrain V; Brouillette J
    Alzheimers Res Ther; 2023 Oct; 15(1):174. PubMed ID: 37833786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology.
    Zavecz Z; Shah VD; Murillo OG; Vallat R; Mander BA; Winer JR; Jagust WJ; Walker MP
    BMC Med; 2023 May; 21(1):156. PubMed ID: 37138290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years.
    Winer JR; Mander BA; Kumar S; Reed M; Baker SL; Jagust WJ; Walker MP
    Curr Biol; 2020 Nov; 30(21):4291-4298.e3. PubMed ID: 32888482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease.
    Lucey BP; McCullough A; Landsness EC; Toedebusch CD; McLeland JS; Zaza AM; Fagan AM; McCue L; Xiong C; Morris JC; Benzinger TLS; Holtzman DM
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic targeting of cortical astrocytes selectively improves NREM sleep in an Alzheimer's disease mouse model.
    Zhao Q; Yokomizo S; Perle SJ; Lee YF; Zhou H; Miller MR; Li H; Gerashchenko D; Gomperts SN; Bacskai BJ; Kastanenka KV
    Sci Rep; 2024 Oct; 14(1):23044. PubMed ID: 39362954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model.
    Zhao Q; Maci M; Miller MR; Zhou H; Zhang F; Algamal M; Lee YF; Hou SS; Perle SJ; Le H; Russ AN; Lo EH; Gerashchenko D; Gomperts SN; Bacskai BJ; Kastanenka KV
    Mol Neurodegener; 2023 Dec; 18(1):93. PubMed ID: 38041158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Duncan MJ; Guerriero LE; Kohler K; Beechem LE; Gillis BD; Salisbury F; Wessel C; Wang J; Sunderam S; Bachstetter AD; O'Hara BF; Murphy MP
    Neuroscience; 2022 Jan; 481():111-122. PubMed ID: 34856352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.
    von Linstow CU; Waider J; Grebing M; Metaxas A; Lesch KP; Finsen B
    Alzheimers Res Ther; 2017 Sep; 9(1):74. PubMed ID: 28899417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed daily activity and reduced NREM slow-wave power in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Kent BA; Michalik M; Marchant EG; Yau KW; Feldman HH; Mistlberger RE; Nygaard HB
    Neurobiol Aging; 2019 Jun; 78():74-86. PubMed ID: 30884411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
    Biyong EF; Tremblay C; Leclerc M; Caron V; Alfos S; Helbling JC; Rodriguez L; Pernet V; Bennett DA; Pallet V; Calon F
    Neurobiol Dis; 2021 Dec; 161():105542. PubMed ID: 34737043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.
    Varga AW; Wohlleber ME; Giménez S; Romero S; Alonso JF; Ducca EL; Kam K; Lewis C; Tanzi EB; Tweardy S; Kishi A; Parekh A; Fischer E; Gumb T; Alcolea D; Fortea J; Lleó A; Blennow K; Zetterberg H; Mosconi L; Glodzik L; Pirraglia E; Burschtin OE; de Leon MJ; Rapoport DM; Lu SE; Ayappa I; Osorio RS
    Sleep; 2016 Nov; 39(11):2041-2048. PubMed ID: 27568802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
    Kent BA; Strittmatter SM; Nygaard HB
    J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer's Disease.
    Lee YF; Gerashchenko D; Timofeev I; Bacskai BJ; Kastanenka KV
    Front Neurosci; 2020; 14():705. PubMed ID: 32714142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer's disease pathology.
    Lee YF; Russ AN; Zhao Q; Perle SJ; Maci M; Miller MR; Hou SS; Algamal M; Zhao Z; Li H; Gelwan N; Liu Z; Gomperts SN; Araque A; Galea E; Bacskai BJ; Kastanenka KV
    Sci Rep; 2023 Aug; 13(1):13075. PubMed ID: 37567942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.